AnaptysBio Stock Quote ANAB - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

36.57

Bid

25.00

Ask

40.24

Volume

229,495

36.50 Day's Range 38.04

13.36 52 Week Range 41.3083

Market Cap

1.104B

Previous Close

37.50

Open

37.50

Last Trade

36.57

Last Trade Time

16:02:20

Financial Volume

$ 8,537,769

VWAP

37.2024

Average Volume (3m)

317,097

Shares Outstanding

30,184,531

Dividend Yield

PE Ratio

-6.74

Earnings Per Share (EPS)

-5.42

Revenue

17.16M

Net Profit

-163.62M

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery techno... AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.anaptysbio.com

Headquarters

Wilmington, Delaware, USA

Founded

AnaptysBio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANAB. The last closing price for AnaptysBio was $37.50. Over the last year, AnaptysBio shares have traded in a share price range of $ 13.36 to $ 41.3083.

AnaptysBio currently has 30,184,531 shares outstanding. The market capitalization of AnaptysBio is $1.13 billion. AnaptysBio has a price to earnings ratio (PE ratio) of -6.74.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.78	5.11641276229	34.79	40.7	34.3769	324689	38.73201788	CS
4	0.21	0.577557755776	36.36	40.7	34.3769	256481	37.53893714	CS
12	12.71	53.2690695725	23.86	41.3083	23.39	317097	33.77086011	CS
26	13.27	56.9527896996	23.3	41.3083	18.49	348715	27.52257298	CS
52	16.97	86.5816326531	19.6	41.3083	13.36	304298	24.50055031	CS
156	9.95	37.3779113449	26.62	41.3083	13.36	262895	24.49627817	CS
260	-8.17	-18.2610639249	44.74	44.99	9.16	332706	21.84837998	CS

Symbol	Price	Vol.
XCURExicure Inc	$ 5.715 (149.56%)	7.99M
VEROVenus Concept Inc	$ 1.13 (124.88%)	13.39M
ZEOZeo Energy Corporation	$ 1.58 (38.60%)	103.2k
TBIOTelesis Bio Inc	$ 1.65 (21.32%)	758.37k
RELIReliance Global Group Inc	$ 3.07 (18.08%)	202.33k
SMFLSmart for Life Inc	$ 0.43 (-44.87%)	2.34M
PGNYProgyny Inc	$ 18.9885 (-22.31%)	131.61k
RGFReal Good Food Company Inc	$ 0.3701 (-13.93%)	28.2k
CRMTAmericas Car Mart Inc	$ 43.75 (-12.43%)	7k
OMEXOdyssey Marine Exploration Inc	$ 1.25 (-10.71%)	4.66M
VEROVenus Concept Inc	$ 1.13 (124.88%)	13.39M
XCURExicure Inc	$ 5.715 (149.56%)	7.99M
EJHE Home Household Service Holdings Ltd	$ 0.1148 (8.30%)	7.56M
NVDANVIDIA Corporation	$ 113.68 (0.27%)	6.19M
OMEXOdyssey Marine Exploration Inc	$ 1.25 (-10.71%)	4.66M

Symbol

Price

Vol.